DelveInsight’s Postoperative Pain Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Postoperative Pain Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Postoperative Pain market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Postoperative Pain: Overview
Postoperative pain is an anticipated and temporary increase in background pain that occurs following surgical procedures. It is a type of pain that typically lasts less than a few days to months or pain directly related to soft tissue damage such as a sprained ankle or a paper cut. The pain is of short duration, but it gradually resolves as the injured tissues heal.
Get access to a free copy of our latest sample report @ https://www.delveinsight.com/sample-request/postoperative-pain-market
Some of the key facts of the Postoperative Pain Market Report
- As per the DelveInsight analysis, the total number of incident cases of postoperative pain in the 7MM were 66,306,970 cases in 2021. These cases are expected to increase by 2032.
- As per the DelveInsight analysis the total incident cases of postoperative pain in the 7MM is expected to increase at a CAGR of 0.85% for the study period 2019–2032.
- As per the DelveInsight analysis, for the total incident cases of postoperative pain in the EU5, Germany was found to occupy the top most spot in 2019 and Spain the bottom of the ladder of incident cases in the year 2021
Postoperative Pain Market
Postoperative Pain market size is anticipated to increase during the study period owing to the increasing incident population and rising awareness of Postoperative Pain in the 7MM. The expected launch of emerging therapies and the research and development activities of pharmaceutical companies will also fuel the market growth during the forecast period.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Postoperative Pain market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives a thorough detail of the Postoperative Pain market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Postoperative Pain Market Insights
There are a number of treatments that can be effective in Postoperative Pain, but still, there are many unmet needs. Alternative pathway therapy has limited effectiveness in preventing hyperammonemia and it needs to be combined with effective dietary management. Therefore, in children with a neonatal-onset disease or in those with very poor metabolic control, liver transplantation is also considered. So, there is an immediate need for R&D activities for the development of novel therapies that can overcome the limitations of existing therapies.
Postoperative Pain Treatment Market
Currently, the treatment pattern consists of different approaches that are classified into pharmacologic and non-pharmacological therapies. Most patients who undergo surgical procedures experience acute postoperative pain, but evidence suggests that less than half report adequate postoperative pain relief. Many preoperative, intraoperative, and postoperative interventions and management strategies are available for reducing and managing postoperative pain. The American Pain Society, with input from the American Society of Anesthesiologists, commissioned an interdisciplinary expert panel to develop a clinical practice guideline to promote evidence-based, effective, and safer postoperative pain management in children and adults. The guideline was subsequently approved by the American Society for Regional Anesthesia. As part of the guideline development process, a systematic review was commissioned on various aspects related to various interventions and management strategies for postoperative pain.
Postoperative Pain Epidemiology
The epidemiology section covers insights about the historical and current Postoperative Pain patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Postoperative Pain Drugs & Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Postoperative Pain market or expected to get launched in the market during the study period. The analysis covers Postoperative Pain market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Postoperative Pain Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Postoperative Pain Companies includes-
- Menarini Group/Guidotti Farma
- AcelRx Pharmaceuticals
- AcelRx Pharmaceuticals
- Trevena, Inc.
- Heron Therapeutics
- Innocoll Pharmaceuticals
- DURECT Corporation
- Pacira Pharmaceuticals
- Baudax Bio
- Bausch & Lomb
- Ocular Therapeutix
- Kala Pharmaceuticals, Inc.
- Medical Developments International Ltd (MVP)
- Bausch & Lomb, and others
Postoperative Pain Therapies includes-
- Enanplus/Takudex (Dexketoprofen/Tramadol)
- Dsuvia/Dzuveo (Sufentanil)
- Zalviso
- Olinvyk (Olinvo) (oliceridine)
- Zynrelef (HTX-011)
- Xaracoll
- Posimir (bupivacaine solution)
- Exparel, and others
View Detailed Report of key players and therapies @ https://www.delveinsight.com/sample-request/postoperative-pain-market
Table of content
- Key Insights
- Executive Summary
- Competitive Intelligence Analysis
- Market Overview at a Glance
- Disease Background and Overview
- Patient Journey
- Epidemiology and Patient Population
- Treatment Algorithm, Current Treatment, and Medical Practices
- Unmet Needs
- Key Endpoints of Postoperative Pain Treatment
- Marketed Products
- Emerging Therapies
- Seven Major Market Analysis
- Attribute analysis
- 7MM: Market Outlook
- Access and Reimbursement Overview
- KOL Views
- Market Drivers
- Market Barriers
- Appendix
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
About Us
DelveInsight is a Business Consulting Services and Market research company, providing expert business solutions for the life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/